Penn Medicine’s newly renovated Immune Health facility will house the Penn Colton Center for Autoimmunity—an anchor of the global Colton Consortium—driving bold, cross-disciplinary collaboration to accelerate transformative discoveries in autoimmune disease research.
.svg)
The Colton Consortium for Autoimmunity has received a $15 million, three-year investment from the Colton Foundation to advance collaborative autoimmune disease research across its partner institutions.
Penn's 2026 Colton Center Autoimmunity Symposium brought together 130 researchers to showcase advances in CAR T cell therapy, AI-driven diagnostics, RNA therapeutics, and novel drug targets across lupus, MS, and type 1 diabetes.
The Colton Consortium proudly sponsored the 2025 FASEB Autoimmunity Conference in Niagara Falls, a leading international forum advancing autoimmune research and fostering collaboration among scientists and clinicians.